Patent Document ID: 20030040518
Application ID: 10169415
Patent Flag: 0

Claim One:
1. An chemical compound represented by the general formula (I) 8 or a pharmaceutically acceptable salt thereof, wherein, represents a group of the formula —C(NOR 2 )— or —NR 2 —CO—; R 1 represents hydrogen or an alkyl group; R 2 represents hydrogen, an alkyl group, an acyl group, an oxo-tetrahydrofuryl group, an isoxazolyl-alkyl group, or an isoxazolyl group, which alkyl group may optionally be substituted with one or more hydroxy or carboxy, and which isoxazolyl group may optionally be substituted with one or more substituents selected from the group consisting of alkyl or alkoxy; R 5 represents a phenyl group, a benzyl group, or a 5 or 6-membered monocyclic heterocyclic group, which groups may optionally be substituted one or more times with halogen, CF 3, —OCF 3, NO 2, amino, aminosulfonyl, alkyl, alkoxy, alkoxycarbonyl, or phenyl; R 6 and R 7 together form a fused 5 to 7 membered ring composed by one of the following bridging bivalent radicals (read in the direction R 6 to R 7 ): —CH 2 —CH 2 — —CH 2 —CH 2 —CH 2 —; —NR 12 —CH 2 —CH 2 —; —CH 2 —CH 2 —NR 12 —; —CH 2 —NR 12 —CH 2 —; —NR 12 —CH 2 —NR 12 —; —CH 2 —CH 2 —CH 2 —CH 2 —; —CH 2 —CH 2 —NR 12 —CH 2 —; —CH 2 —NR 12 —CH 2 —CH 2 —; —CH 2 —CH 2 —CH 2 —NR 12 —; —NR 12 —CH 2 —CH 2 —CH 2 —; —NR 12 —CH 2 —CH 2 —NR 12 —; —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —; —CH 2 —CH 2 —NR 12 —CH 2 —CH 2 —; —CH 2 —CH 2 —CH 2 —NR 12 —CH 2 —; —CH 2 —NR 12 —CH 2 —CH 2 —CH 2 —; —CH 2 —CH 2 —CH 2 —CH 2 —NR 12 —; or —NR 12 —CH 2 —CH 2 —CH 2 —CH 2 —; wherein R 12 represents hydrogen, a group of the formula —CH 2 CH 2 OH, —CO—CH 3, —SO 2 —CH 3, or an alkyl group; or R 6 and R 7 independently of each other represent hydrogen or methyl.